Task: Answer the multiple-choice question.
Query: Which drug exhibits a -8.833% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. COc1ccc(CNc2nc(-c3cccnc3)nn2S(C)(=O)=O)cc1
b. CC(C)OC(=O)c1ccc(COC(=O)c2cnccn2)cc1
c. Cc1ccc(S(=O)(=O)N2CCOCC2)cc1C(=O)NCc1ccc(F)cc1
d. CC(CN1CCCCC1)OC(=O)c1ccc2c(c1)OCCO2.Cl
Answer: d. CC(CN1CCCCC1)OC(=O)c1ccc2c(c1)OCCO2.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(CN1CCCCC1)OC(=O)c1ccc2c(c1)OCCO2.Cl
CC(CN1CCCCC1)OC(=O)c1ccc2c(c1)OCCO2.Cl
1-piperidin-1-ylpropan-2-yl 2,3-dihydro-1,4-benzodioxine-6-carboxylate;hydrochloride